Navigation Links
Modigene to Present at the BIO-Europe Spring(R) 2009 Conference
Date:3/10/2009

NES-ZIONA, Israel, March 10 /PRNewswire/ -- Modigene Inc. (OTC Bulletin Board: MODG), a biopharmaceutical company developing a long-acting human growth hormone and other proprietary longer-acting versions of already approved therapeutic proteins, today announced that CEO Avri Havron will present at the upcoming BIO-Europe Spring(R) 2009 Conference at 10:00 AM (local time) on March 17, 2009. The conference will be held at the Milano Convention Center in Milan, Italy from March 16-18, 2009.

For more information about the BIO-Europe Spring(R) 2009 Conference, visit http://www.ebdgroup.com/bes/

ABOUT MODIGENE

Modigene Inc. is a biopharmaceutical company applying its patented CTP technology to develop longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The CTP technology is applicable to virtually all proteins, and Modigene is currently developing long-acting versions of human growth hormone, interferon beta and erythropoietin, which are in late preclinical development, as well as GLP-1. For more information on Modigene, visit www.modigeneinc.com.

    MODIGENE CONTACT:                         MEDIA CONTACT:
    Shai Novik, President                     Barbara Lindheim
    Modigene Inc.                             GendeLLindheim BioCom Partners
    Tel: +1 866 644-7811                      +1 212 918-4650
    Email: shai@modigeneinc.com


'/>"/>
SOURCE Modigene Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Modigene Sets Record Date for Annual Meeting of Shareholders
2. Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone
3. Modigene to Present at the UBS Global Life Sciences Conference
4. Modigene to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
5. Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
6. Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
7. Modigene to Present at the Roth 2007 New York Investor Conference
8. NxStage to Present at the Cowen and Company 29th Annual Healthcare Conference
9. WaferGen to Present Data on SmartChip(TM) Real-Time PCR System at Cambridge Healthtech Institutes Quantitative PCR Conference
10. Kendle to Present at Upcoming Barclays Capital and Raymond James Conferences
11. Cynvec LLC(SM) to Present at the Cowen and Company 29th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... 2017 , ... Today Aether announced that Aether and University of South Australia ... Melinda Gates Foundation grant, to pursue a 3D bioprinting research breakthrough ... the Gates Foundation, is said to be the largest transparently operated private foundation in ...
(Date:8/18/2017)... ... August 18, 2017 , ... OAI, a leading Silicon ... Microfluidics Industries, announces the new Model 800E front and backside, semi-automatic mask aligner ... mask aligners. OAI has already received and installed several orders for the ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... cancer research and personalized medicine, today announced the launch of a new breast ... Missouri. The study’s goal is to evaluate the potential for early detection of ...
(Date:8/16/2017)... Phoenix, Arizona (PRWEB) , ... ... ... is proud to introduce the Fluidnatek® Electrospinning and Electrospraying ... and electrospraying equipment scales from table-top equipment for the lab to fully ...
Breaking Biology Technology:
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
Breaking Biology News(10 mins):